MedTrace Logo

Evaluating the Efficacy and Safety of Yi-Gan San in Children and Adolescents With Tourette's Disorder

NCT03564132 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2023-04-27

No results posted yet for this study

Summary

Yigansan was used in Ming dynasty by Xue Kai as a remedy for restlessness and agitation in children. We expect that the total YGTSS scores of Yigansan-treated subjects will be significantly reduced compared to that of placebo-treated subjects.

Conditions

  • Tourette Disorder
  • Tic Disorders

Interventions

DRUG

Yigansan

Yigansan granules

DRUG

Placebo

One-tenth concentration of Yigansan manufactured to mimic Yigansan granules

Sponsors & Collaborators

  • China Medical University Hospital

    lead OTHER

Principal Investigators

  • Cheng-Hao Huang · China Medical University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-16
Primary Completion
2020-08-15
Completion
2022-08-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03564132 on ClinicalTrials.gov